Fillion M - Search Results

1

False-negative Results of Human Immunodeficiency Virus (HIV) Rapid Testing in HIV Controllers.

Hage-Sleiman M, Tremeaux P, Fillion M, Boufassa F, Melard A, Gardiennet E, Mariaggi AA, Plantier JC, Rouzioux C, Lambotte O, Avettand-Fenoel V; CODEX ANRS Cohort Study Group. Hage-Sleiman M, et al. Among authors: fillion m. Clin Infect Dis. 2020 Apr 10;70(8):1754-1757. doi: 10.1093/cid/ciz734. Clin Infect Dis. 2020. PMID: 31541253

2

Initiating Antiretroviral Treatment Early in Infancy Has Long-term Benefits on the Human Immunodeficiency Virus Reservoir in Late Childhood and Adolescence.

Avettand-Fenoel V, Lechenadec J, Diallo MS, Fillion M, Melard A, Samri A, Dollfus C, Blanche S, Faye A, Amokrane K, Autran B, Buseyne F, Warszawski J, Frange P; ANRS-EP59-CLEAC Study Group. Avettand-Fenoel V, et al. Among authors: fillion m. Clin Infect Dis. 2021 Dec 6;73(11):e4214-e4222. doi: 10.1093/cid/ciaa1931. Clin Infect Dis. 2021. PMID: 34355738

3

Factors associated with the emergence of integrase resistance mutations in patients failing dual or triple integrase inhibitor-based regimens in a French national survey.

Marcelin AG, Charpentier C, Bellecave P, Abdi B, Chaix ML, Ferre V, Raymond S, Fofana D, Bocket L, Mirand A, Le Guillou-Guillemette H, Montes B, Amiel C, Pallier C, Fafi-Kremer S, De Monte A, Alessandri-Gradt E, Scholtes C, Maillard A, Jeulin H, Bouvier-Alias M, Roussel C, Dos Santos G, Signori-Schmuck A, Dina J, Vallet S, Stefic K, Soulié C, Calvez V, Descamps D, Flandre P; ANRS-MIE AC43 Group. Marcelin AG, et al. J Antimicrob Chemother. 2021 Aug 12;76(9):2400-2406. doi: 10.1093/jac/dkab193. J Antimicrob Chemother. 2021. PMID: 34100068

4

Production and characterization of an antibody directed against the mouse 5HT1B receptor.

Grimaldi B, Cloez-Tayarani I, Fillion MP, Mazie JC, Hen R, Fillion G. Grimaldi B, et al. Among authors: fillion g, fillion mp. Neurosci Res. 1995 Dec;24(1):97-101. doi: 10.1016/0168-0102(95)00974-4. Neurosci Res. 1995. PMID: 8848295 Free article.

5

Acute stress induces a differential increase of 5-HT-moduline (LSAL) tissue content in various rat brain areas.

Bonnin A, Grimaldi B, Fillion MP, Fillion G. Bonnin A, et al. Among authors: fillion g, fillion mp. Brain Res. 1999 Apr 17;825(1-2):152-60. doi: 10.1016/s0006-8993(99)01265-2. Brain Res. 1999. PMID: 10216182

Rousseau, M. Plantefol, R. Hen, G. Fillion, 5-Hydroxytryptamine-moduline, a new endogenous cerebral peptide, controls the serotonergic activity via its specific interaction with 5-hydroxytryptamine1B/1D receptors, Mol. ...Chem. 271 (1996) 726-735; J.C. Rousselle, …

Rousseau, M. Plantefol, R. Hen, G. Fillion, 5-Hydroxytryptamine-moduline, a new endogenous cerebral peptide, controls the sero …

6

5-Hydroxytryptamine-moduline: a novel endogenous peptide involved in the control of anxiety.

Grimaldi B, Bonnin A, Fillion MP, Prudhomme N, Fillion G. Grimaldi B, et al. Among authors: fillion g, fillion mp. Neuroscience. 1999;93(4):1223-5. doi: 10.1016/s0306-4522(99)00322-x. Neuroscience. 1999. PMID: 10501445

7

Molecular cloning of two partial serotonin 5-HT1D receptor sequences in mouse and one in guinea pig.

Weydert A, Cloez-Tayarani I, Fillion MP, Simon-Chazottes D, Guenet JL, Fillion G. Weydert A, et al. Among authors: fillion g, fillion mp. C R Acad Sci III. 1992;314(10):429-35. C R Acad Sci III. 1992. PMID: 1521164

8

The serotonin 5-HT1B receptor subtype (Htr1b) gene maps to mouse chromosome 9.

Simon-Chazottes D, Cloez-Tayarani I, Fillion MP, Guénet JL, Fillion G. Simon-Chazottes D, et al. Among authors: fillion g, fillion mp. Mamm Genome. 1993;4(7):397-8. doi: 10.1007/BF00360593. Mamm Genome. 1993. PMID: 8358175 No abstract available.

9

A new peptide, 5-HT-moduline, isolated and purified from mammalian brain specifically interacts with 5-HT1B/1D receptors.

Fillion G, Rousselle JC, Massot O, Zifa E, Fillion MP, Prudhomme N. Fillion G, et al. Among authors: fillion mp. Behav Brain Res. 1996;73(1-2):313-17. doi: 10.1016/0166-4328(96)00120-9. Behav Brain Res. 1996. PMID: 8788526

10

5-hydroxytryptamine-moduline, a new endogenous cerebral peptide, controls the serotonergic activity via its specific interaction with 5-hydroxytryptamine1B/1D receptors.

Massot O, Rousselle JC, Fillion MP, Grimaldi B, Cloëz-Tayarani I, Fugelli A, Prudhomme N, Seguin L, Rousseau B, Plantefol M, Hen R, Fillion G. Massot O, et al. Among authors: fillion g, fillion mp. Mol Pharmacol. 1996 Oct;50(4):752-62. Mol Pharmacol. 1996. PMID: 8863819

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

104 results

Search Page

Filters